Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors.
William F MaguireJohn C SchmitzJonas ScemamaKen CzambelYan LinAnthony G GreenShaoyu WuHuang LinShannon PuhallaJohn RheeRonald StollerHussein TawbiJames J LeeJohn J WrightJan H BeumerEdward ChuLeonard J Applemannull nullPublished in: Cancer chemotherapy and pharmacology (2021)
NCT01749384 (First posted 12/13/2012).